يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Kristine Bennedsgaard"', وقت الاستعلام: 0.98s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3

    المساهمون: Aarhus University [Aarhus], Aarhus University Hospital, VIA University College, Physiopathologie et Pharmacologie Clinique de la Douleur (LPPD), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Ambroise Paré [AP-HP], Universiteit Gent = Ghent University (UGENT), University of Oxford, University Hospital of Southern Denmark, Eli Lilly and Company, AstraZeneca, Novartis Pharma, Horizon 2020 Framework Programme, H2020: 633491, Biotechnology and Biological Sciences Research Council, BBSRC, Innovative Medicines Initiative, IMI, Research funding: This work was supported by the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 633491 (DOLORisk). The funding source had no involvement in the conduct of the study, manuscript preparation, or decision to publish., Competing interests: The authors declare no conflict of interest. Outside the submitted work, DB has acted as consultant for Grünenthal, Novartis, Bayer, Air Liquide, Vertex, and Angelini. Outside the submitted work, DLB has acted as a consultant on behalf of Oxford Innovation for Amgen, Bristows, LatigoBio, GSK, Ionis, Lilly, Olipass, Orion, Regeneron and Theranexus over the last 2 years. He has received research funding from Lilly and has received an industrial partnership grant from the BBSRC and AstraZeneca outside the submitted work. NA has received honoraria from Pfizer, Grunenthal, Novartis, Upsa, Merz Pharma, Air Liquide, and Biogen outside the submitted work. NBF reports personal fees from Almirall, NeuroPN, Novartis Pharma, and Vertex and has undertaken consultancy work for Aarhus University with remunerated work for Biogen, Merz, and Confo Therapeutics, outside the submitted work and has received a grant from IMI2PainCare an EU IMI 2 (Innovative Medicines Initiative) public-private consortium and the companies involved are: Grünenthal, Bayer, Eli Lilly, Esteve, and Teva, outside the submitted work., European Project: 633491,H2020,H2020-PHC-2014-two-stage,DOLORisk(2015)

    المصدر: SCANDINAVIAN JOURNAL OF PAIN
    Bennedsgaard, K, Grosen, K, Attal, N, Bouhassira, D, Crombez, G, Jensen, T S, Bennett, D L, Ventzel, L, Andersen, I S & Finnerup, N B 2023, ' Neuropathy and pain after breast cancer treatment : A prospective observational study ', Scandinavian Journal of Pain, vol. 23, no. 1, pp. 49-58 . https://doi.org/10.1515/sjpain-2022-0017Test
    Scandinavian Journal of Pain
    Scandinavian Journal of Pain, 2023, 23 (1), pp.49-58. ⟨10.1515/sjpain-2022-0017⟩

    وصف الملف: application/pdf

  4. 4

    المصدر: Themistocleous, A C, Kristensen, A G, Sola, R, Gylfadottir, S S, Bennedsgaard, K, Itani, M, Krøigård, T, Ventzel, L, Sindrup, S H, Jensen, T S, Bostock, H, Serra, J, Finnerup, N B, Tankisi, H & Bennett, D L H 2022, ' Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study ', Annals of Neurology, vol. 91, no. 4, pp. 506-520 . https://doi.org/10.1002/ana.26319Test

    وصف الملف: application/pdf

  5. 5
  6. 6
  7. 7

    المصدر: Journal of the Peripheral Nervous System
    Bennedsgaard, K, Ventzel, L, Andersen, N T, Themistocleous, A C, Bennett, D L, Jensen, T S, Tankisi, H & Finnerup, N B 2020, ' Oxaliplatin-and docetaxel-induced polyneuropathy : clinical and neurophysiological characteristics ', Journal of the Peripheral Nervous System, vol. 25, no. 4, pp. 377-387 . https://doi.org/10.1111/jns.12413Test

    وصف الملف: application/pdf

  8. 8
  9. 9

    المصدر: Kyng, K J, Kerrn-Jespersen, S, Bennedsgaard, K, Skajaa, T, Pedersen, M, Holm, I E & Henriksen, T B 2021, ' Short-term outcomes of remote ischemic postconditioning 1 h after perinatal hypoxia-ischemia in term piglets ', Pediatric Research, vol. 89, no. 1, pp. 150-156 . https://doi.org/10.1038/s41390-020-0878-6Test

  10. 10

    المصدر: Bennedsgaard, K, Ventzel, L, Themistocleous, A C, Bennett, D L, Jensen, A B, Jensen, A R, Andersen, N T, Jensen, T S, Tankisi, H & Finnerup, N B 2020, ' Long-term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy ', Cancer Medicine, vol. 9, no. 14, pp. 5114-5123 . https://doi.org/10.1002/cam4.3129Test
    Cancer Medicine
    Cancer Medicine, Vol 9, Iss 14, Pp 5114-5123 (2020)